Related Experiment Videos

C-reactive protein is an essential aspect of cardiovascular risk factor stratification

Edward T H Yeh1

  • 1The University of Texas MD Anderson Cancer Center, Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas Houston Health Science Center, Houston, Texas 77030, USA.

The Canadian Journal of Cardiology
|August 17, 2004
PubMed

Insights

C-reactive protein (CRP) is a key inflammation marker. Measuring CRP with cholesterol levels offers the best cardiovascular event risk prediction, as CRP may locally promote atherosclerosis within blood vessel walls.

Area of Science:

  • Biochemistry
  • Cardiology
  • Immunology

Background:

  • C-reactive protein (CRP) is a recognized inflammation marker.
  • Low-density lipoprotein cholesterol is also a key cardiovascular risk indicator.
  • Combined CRP and lipid panel measurements offer superior cardiovascular risk assessment.

Purpose of the Study:

  • To highlight the predictive value of C-reactive protein (CRP) in cardiovascular events.
  • To explore the proatherogenic mechanisms of CRP.
  • To investigate the local production and effects of CRP in the vascular wall.

Main Methods:

  • Analysis of existing data on CRP and cardiovascular events.
  • Review of studies on CRP's interaction with vascular cells.
  • Examination of research demonstrating CRP production by vascular smooth muscle cells.

Main Results:

  • CRP, alongside lipid panels, provides the best available cardiovascular risk prediction.
  • CRP exhibits proatherogenic properties by activating endothelial and smooth muscle cells.
  • Vascular smooth muscle cells can produce CRP in response to inflammatory cytokines.

Conclusions:

  • CRP's role extends beyond a mere marker; it actively contributes to atherosclerosis.
  • Local CRP production within the vascular wall may drive proatherogenic effects.
  • Integrating CRP measurement into routine cardiovascular risk assessment is clinically valuable.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...